Ultra-Early Tumor Screening
Utilizing genome sequencing, PCR, bioinformatics, flow, mass spectrometry, etc., to build the most socially influential precision medicine testing platform from the molecular, cellular, and protein analysis levels.
Promoting the development of the health industry and the improvement of people's health and well-being.
We specialize in selecting safe and innovative biotechnologies to offer to our clients and accompanying them in their family's health management.
The company has been strictly screened to act as an agent of various biotechnology products, and has established close cooperation with a number of well-known scientific research institutions and universities, the products are widely used in anti-aging, health risk management and other areas. We assist our customers to build their own health management programs, establish correct health management concepts, and better enjoy the splendor of life.
100+
ten thousand
Fingerprint data
1200
ten thousand
sample testing
67.5
%
High incidence of five cancer cases, accounting for all cancer cases
40.9
%
Lung and liver cancer cases, which account for all cancer cases.
Authoritative organization certification
Build reputation with strength
Technical Audit Certificate of Compliance (NO.000242)
2023.11.16
PCR Biosafety Filing Certificate
2023.8.18
Medical Device License
2023.11.3
License to practice in medical institutions
2024.11.28
Medical Advertisement Audit Certificate
2025.2.26
Qualification certificate for transportation of blood samples by air, land and sea
-
State-owned background-State-controlled (equity participation) enterprises
-
Technical endorsement-Domestic + international top scientific research, technical support
-
Strong database of methylated fingerprints
-
Awarded Cancer Science Me-DIP-Seq Certificate of Merit
-
A number of patents for inventions and utility models
Team of Experts
Prof. Nie Jinfu
(Jeff . Nie)
Initiator of the Center for Precision Medicine at Mayo Hospital, USA
Chinese Academy of Sciences "Hundred Talents Program" Experts
Chinese Academy of Sciences "Hundred Talents Program" Experts
With 20 years of experience in early cancer screening and bioinformatics analysis, Nie has published more than 40 papers in international authoritative journals, and many of his R&D results in precision medicine have been successfully applied in the clinical practice of Mayo Hospital.
In 2017, the Chinese Academy of Sciences (CAS) introduced Researcher Nie Jinfu back to China through the "Hundred Talents Program" and set up a national special fund to support his research on early cancer screening program in China.
Relying on the medical resources of Hefei Cancer Hospital of Chinese Academy of Sciences, he has accomplished the transformation of many major scientific research achievements.
- Initiator of the Center for Precision Medicine at Mayo Hospital, USA
- Visiting Professor, Hong Kong Institute of Innovation, Chinese Academy of Sciences
- Researcher, Hefei Institute of Materials Science, Chinese Academy of Sciences
- Researcher, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, China
- Director, Bioinformatics Research Laboratory, Hefei Institute of Materials Science, Chinese Academy of Sciences, China
- Chief Scientist of Zhongke Jinchen & Zhongsheng Precision Medicine Laboratory
Study suggests early screening and diagnosis is the best "medicine" for tumors.
Early detection = high cure rate + high prognosis quality of life + less pain + less expense
